YouTube/University of Oxford
- The Serum Institute of India said it is going to start making a still-experimental coronavirus vaccine while it is still on trial.
- The Oxford Vaccine Group is currently running human trials on the hAdOx1 nCoV-19 vaccine, but won't be done until September. There is no guarantee it will work.
- Human trials started in Oxford on Thursday. The group is targeting September for an effective product — but there is no guarantee it will work.
- Serum Institute CEO Adar Poonawalla said on Monday: "The decision — at our own risk and cost — has been solely taken to get a jump-start on manufacturing."
- Visit Business Insider's homepage for more stories.
The world's largest vaccine maker is mass-producing a coronavirus vaccine developed by the University Oxford without knowing if it works.
The Serum Institute of India — which produces 1.5 billion vaccine doses each year for an array of diseases — said it will start production before the autumn target date of the Oxford trial.
See the rest of the story at Business Insider
NOW WATCH: How the Navy's largest hospital ship can help with the coronavirus
See Also:
- France has banned online sales of nicotine substitutes after a study showed smokers are less likely to be admitted for COVID-19
- Should you turn off your air-conditioning if someone is sick with coronavirus in your home? Here's what you need to know.
- A leading disinfectant company urged people not to inject themselves with its products, hours after Trump said it might kill the coronavirus inside the human body
from Business Insider https://ift.tt/3aFTlmU
No comments:
Post a Comment